Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Treatment for Children and Adolescents With Juvenile Idiopathic Arthritis in Sustained Remission: a Comparison of Three Treatment Strategies. The MOVE-JIA Trial

NCT06653634 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT06653634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06653634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Treatment for Children and Adolescents With Juvenile Idiopathic Arthritis in Sustained Remission: a Comparison of Three Treatment Strategies. The MOVE-JIA Trial
Lead sponsor
Oslo University Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
October 24, 2024
Completion date
December 31, 2029
Enrollment
150 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile idiopathic arthritis